{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:53:22Z","timestamp":1648670002249},"reference-count":10,"publisher":"Walter de Gruyter GmbH","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"DOI":"10.1515\/cclm-2012-0658","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T11:11:53Z","timestamp":1363259513000},"page":"e183-e186","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility of serum tumor markers and cytokines in cervical cancer and neoplasia"],"prefix":"10.1515","volume":"51","author":[{"given":"Li","family":"Juan","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-li","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-hong","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-zhu","family":"Nan","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ping","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing, 100853, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"2021120919153048366_j_cclm-2012-0658_ref_001","unstructured":"Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am Fam Physician 2003;68:1075\u201382.14524394"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_002","unstructured":"Trape J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer A, Rigo-Bonnin R. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 2011;49:1605\u201320.http:\/\/gateway.webofknowledge.com\/gateway\/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000296591500004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f321892908"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_003","doi-asserted-by":"crossref","unstructured":"Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, etal. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol Oncol 2000;77:164\u201370.10.1006\/gyno.2000.5732","DOI":"10.1006\/gyno.2000.5732"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_004","doi-asserted-by":"crossref","unstructured":"Beastall GH, Watson ID. Clinical chemistry and laboratory medicine: an appreciation. Clin Chem Lab Med 2013;51:3\u20134.10.1515\/cclm-2012-054623152420","DOI":"10.1515\/cclm-2012-0546"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_005","doi-asserted-by":"crossref","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073\u201381.10.1093\/carcin\/bgp127http:\/\/gateway.webofknowledge.com\/gateway\/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000267666100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f319468060","DOI":"10.1093\/carcin\/bgp127"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_006","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646\u201374.10.1016\/j.cell.2011.02.013http:\/\/gateway.webofknowledge.com\/gateway\/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000288007100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f321376230","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_007","unstructured":"Fujimoto J, Sakaguchi H, Aoki I, Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000;60:2632\u20135.10825134"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_008","doi-asserted-by":"crossref","unstructured":"Wei LH, Kuo ML, Chen CA, Cheng WF, Cheng SP, Hsieh FJ, etal. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 2001;82:49\u201356.10.1006\/gyno.2001.6235","DOI":"10.1006\/gyno.2001.6235"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_009","doi-asserted-by":"crossref","unstructured":"Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, etal. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 2003;22:1517\u201327.10.1038\/sj.onc.1206226","DOI":"10.1038\/sj.onc.1206226"},{"key":"2021120919153048366_j_cclm-2012-0658_ref_010","doi-asserted-by":"crossref","unstructured":"Bermudez-Morales VH, Peralta-Zaragoza O, Alcocer-Gonzalez JM, Moreno J, Madrid-Marina V. IL-10 expression is regulated by HPV E2 protein in cervical cancer cells. Mol Med Report 2011;4:369\u201375.http:\/\/gateway.webofknowledge.com\/gateway\/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000287785800028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3","DOI":"10.3892\/mmr.2011.429"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2012-0658\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2012-0658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T20:01:42Z","timestamp":1639080102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2012-0658\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,5,7]]},"published-print":{"date-parts":[[2013,8,1]]}},"alternative-id":["10.1515\/cclm-2012-0658"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2012-0658","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}